Oncotarget | NOTCH1 Variants in Triple-Negative Breast Cancer

(1:)

NOTCH1: The Clinical and Basic Science Behind it

(13:26)

Oncotarget: ONC201, TRAIL, and Breast Cancer

(52)

Oncotarget | Genomic and Neoantigen Evolution in Head and Neck Squamous Cell Carcinoma

(9:23)

Utilizing the NOTCH1 pathway in the treatment of CLL

(1:37)

Oncotarget: Transcription and proliferation of human tumor cells

(7:54)

Oncotarget: BMP9/ALK1 inhibits neovascularization

(9:3)

Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria

(12:54)

Notch Signaling Pathway | Purpose and Mechanism

(5:21)

Spyros Artavanis-Tsakonas, “A Notch Signaling Story: It All Started at Yale“

(46:51)

Targeting Tumor Associated Macrophages in Ovarian Cancer

(31:11)

How do natural killer cells target cancer?

(4:10)

Increase Your Mitochondria, Your Body Will Thank You | The Acid Drop

(11:7)

MIT CompBio Lecture 22 - Cancer Genomics (Fall 2019)

(1:26:33)

Mechanism of NOTCH SIGNALING PATHWAY

(3:13)

Bioplastics: DIY Casein. Precipitating Casein from milk. The backbone of bioplastics made from milk

(8:58)

Understanding Development: The Notch Signaling Pathway

(6:38)

Making a Doctor #10YearChallenge | COMPLETE Stats \u0026 Experiences

(17:50)

Oncotarget | Genomic and Neoantigen Evolution in Head, Neck Cancer

(55)

Oncotarget: Camptothecin targets WRN protein: in clinical breast cancer

(7:39)

Oncotarget: mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC

(54)

Oncotarget | Neoantigen Evolution in Head and Neck Tumors

(46)

Oncotarget: Akt Antagonist Drug and Th1 Cytokines Combat Breast Cancer

(53)

Genomics Has More to Reveal | Oncotarget

(1:27)

Generative AI in Cancer Imaging: Revolutionizing Detection \u0026 Diagnosis | Oncotarget

(1:6)

Learning More About Notch1 Mutations

(2:44)

GPR141 Mediates Breast Cancer Proliferation and Metastasis | Oncotarget

(2:33)

Oncotarget: T-Cell-Targeted Immunotherapy for Recurrent HNSCC

(57)

Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget

(6:47)